Skip to content
Lower risk Medical device recall · FDA · Published August 11, 2025

Siemens Atellica UCFP Test May Give False Low Results - Recall

Siemens Healthcare recalls Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP) tests with material number 11097543 due to potential false low results in patient testing.

🇺🇸 FDA recall #Z-2542-2025Medical deviceSiemens Healthcare ›
Take action

Contact the company

Recalling firmSiemens Healthcare Diagnostics, Inc.511 Benedict Ave · Tarrytown, NY 10591-5005
✎ GovInfoNow plain-language explainer

Siemens Healthcare is recalling Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP) tests that may give false low results in patient testing. This could lead to inaccurate quality control or calibration results, affecting diagnosis and treatment decisions. Read more at govinfonow.com/recall/51647-siemens-atellica-ucfp-test-may-give-false-low-results-recall.

Source Summary by GovInfoNow · govinfonow.com/recall/51647-siemens-atellica-ucfp-test-may-give-false-low-results-recall · Updated August 17, 2026 · FDA enforcement record: FDA #Z-2542-2025

Cite this page

“Siemens Atellica UCFP Test May Give False Low Results - Recall.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/51647-siemens-atellica-ucfp-test-may-give-false-low-results-recall. Based on FDA recall #Z-2542-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2542-2025%22&limit=1).

The FDA announced on Aug. 11, 2025, that Siemens Healthcare Diagnostics is recalling Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP) due to the potential for falsely depressed or delayed results. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Siemens Healthcare
  • Product: Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP)
  • Material Number: 11097543
  • Test Code: UCFP
  • UDI-DI: 00630414279206
  • Lot numbers: All lot numbers
  • Units affected: 11,811

The hazard

The recall cites the potential for falsely depressed patient, quality control (QC), and/or calibration results or delayed results. The FDA said this could impact diagnostic accuracy.

Context

GovInfoNow's records show Siemens Healthcare Diagnostics has had 150 other recalls since June 7, 2017. Other recent recalls of similar products include Vivoo Protein Test Recall (Nov. 22, 2025), Fujirebio Lumipulse G Amyloid 1-42 Plasma Calibrators Recall (Dec. 11, 2025), and Changchun Wancheng Bio-Electron UTI Test Strips Recall (Nov. 22, 2025).

How to tell if you have this one

Check for the material number 11097543 on the test kit. The product is sold under the Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP) name with test code UCFP.

  • Brand
    Siemens Healthcare
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Test Kit

    Look for the material number 11097543 on the test kit label.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide and the countries of Argentina, Australia, Austria, Bahamas, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cura¿ao,¿St¿Eus, Czech¿Republic, Denmark, Egypt,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 37 days after the firm started it.

1. Firm started the recall: Aug 11, 202512. FDA classified it Class II: Sep 8, 202523. Published in FDA’s Enforcement Report: Sep 17, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is there a risk of serious injury from this test?

No serious injury risk is described in the recall notice. The hazard is limited to potential inaccurate test results.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2542-2025 (August 11, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2542-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA